Lotus Pharmaceutical Co., Ltd.
TAI: 1795.TW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Petar Antonov Vazharov
- Employees
- 1,099
- Headquarters
- Taipei, Taiwan
- IPO year
- 2007
- Market cap
- NT$62.2B
- Website
- https://www.lotuspharm.com.tw
Loading 1795…
Loading profile data…Frequently asked questions about 1795
What does Lotus Pharmaceutical Co., Ltd. (1795.TW) do?
Lotus Pharmaceutical Co., Ltd. research, develops, manufactures, and sells generic pharmaceutical products in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system disease. The company also sells...
Where does 1795.TW trade?
Lotus Pharmaceutical Co., Ltd. (1795.TW) trades on the Taiwan Stock Exchange.
What sector is 1795.TW in?
Lotus Pharmaceutical Co., Ltd. (1795.TW) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Lotus Pharmaceutical Co., Ltd.?
Petar Antonov Vazharov is the chief executive officer of Lotus Pharmaceutical Co., Ltd. (1795.TW).
Where is Lotus Pharmaceutical Co., Ltd. headquartered?
Lotus Pharmaceutical Co., Ltd. is headquartered in Taiwan.
Does 1795.TW pay a dividend?
Yes — Lotus Pharmaceutical Co., Ltd. (1795.TW) paid a trailing twelve-month dividend of TWD 5.78 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1795.TW go public?
Lotus Pharmaceutical Co., Ltd. (1795.TW) completed its initial public offering in 2007.